Department of Family and Community Medicine, Centro de Salud Barrio del Pilar, Area 5, Madrid, Spain.
Department of Internal Medicine, Hospital Cantoblanco-La Paz, Universidad Autonoma de Madrid, Madrid, (IdiPAZ), Spain.
Clin Kidney J. 2012 Feb;5(1):37-40. doi: 10.1093/ndtplus/sfr121. Epub 2012 Jan 28.
There is an increased awareness of the adverse consequences of nutritional vitamin D deficiency. We report a patient with chronic tophaceous gout, chronic kidney disease (CKD) Stage 3/4 and undetectable serum calcidiol who developed severe hypercalcaemia upon vitamin D supplementation despite serum 25(OH) vitamin D within the normal range. Upon recovery, serum 1,25(OH)2 vitamin D remained in the normal range despite CKD and serum 25(OH) vitamin D 6 ng/mL. Gout tophi biopsies from additional patients showed macrophage expression of 25(OH) vitamin D 1α-hydroxylase. This case illustrates the dangers of supplementing vitamin D in patients with low serum 25(OH) vitamin D and increased 1α-hydroxylase activity due to granulomatous disease.
人们越来越意识到营养性维生素 D 缺乏的不良后果。我们报告了一例慢性痛风石性痛风、慢性肾脏病(CKD)3/4 期和无法检测到血清钙二醇的患者,尽管血清 25(OH) 维生素 D 在正常范围内,但在补充维生素 D 后仍发生严重高钙血症。恢复后,尽管 CKD 和血清 25(OH) 维生素 D 为 6ng/ml,但血清 1,25(OH)2 维生素 D 仍在正常范围内。来自其他患者的痛风石活检显示巨噬细胞表达 25(OH) 维生素 D 1α-羟化酶。该病例说明了由于肉芽肿病导致低血清 25(OH) 维生素 D 和增加 1α-羟化酶活性的患者补充维生素 D 的危险。